Skip to main content
Caplight Logo









Molecular Forecaster Inc.

Molecular Forecaster Inc.

Private
MontrealHealthcare & Life Scienceshttps://molecularforecaster.com/

Last Round

Grant

Sep 28, 2021

Total Funding Raised

$787,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Molecular Forecaster Inc. is a computational chemistry company that provides research-as-a-service (RaaS) and proprietary software for small molecule drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

computational chemistrydrug discoveryvirtual screeningin silico drug discoverybinding affinity predictionmolecular dockingmedicinal chemistrylead optimizationresearch-as-a-serviceRaaScontract research organizationCROsmall-molecule discoverystructure-activity relationshipSARai drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecular Forecaster Inc. Comparables

Compare Molecular Forecaster Inc. with similar companies based on industry and business-model similarity.

Molecular Forecaster Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioSolveIT
87%
Molsoft LLC
86%
Chemical Computing Group
84%

Molecular Forecaster Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 28, 2021

Key People

Founding team and executive leadership

Josh Pottel

CEO

Executive Team

Molecular Forecaster Inc. Investors

Notable investors and investment history

Molecular Forecaster Inc. investors
InvestorRounds
Investissement QuébecGrant
Génome QuébecGrant
Consortium Québécois sur la découverte du médicamentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 18, 2026

    Grew 16% QoQ, from 19 to 22 employees.

  • Jul 27, 2026

    Grew 22% QoQ, from 18 to 22 employees.

Molecular Forecaster Inc. Filings

Explore SEC and related filing metadata, where available.

Molecular Forecaster Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Molecular Forecaster Inc.'s valuation, stock price, and market status.

Is Molecular Forecaster Inc. a public or private company?

Molecular Forecaster Inc. is a private company.

What is the current stock price of Molecular Forecaster Inc.?

Molecular Forecaster Inc. is a private company with no public stock price. Caplight tracks Molecular Forecaster Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Molecular Forecaster Inc. worth (valuation)?

Valuation information for Molecular Forecaster Inc. is not publicly available.

Can I buy Molecular Forecaster Inc. stock?

Molecular Forecaster Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Molecular Forecaster Inc.'s last funding round?

Molecular Forecaster Inc.'s most recent funding round was Grant on September 28, 2021.

Who are the main investors in Molecular Forecaster Inc.?

Key investors in Molecular Forecaster Inc. include Investissement Québec, Génome Québec, Consortium Québécois sur la découverte du médicament.

Will Molecular Forecaster Inc. IPO soon?

No public IPO plans have been announced for Molecular Forecaster Inc..

How can I track Molecular Forecaster Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Molecular Forecaster Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range18
Year Founded2010
Last FundingSep 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?